comparemela.com

Latest Breaking News On - Inhaled ampion - Page 1 : comparemela.com

Ampio Pharmaceuticals (NYSE:AMPE) Receives New Coverage from Analysts at StockNews com

Analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a research report issued on Sunday. The brokerage set a “sell” rating on the stock. Shares of NYSE AMPE opened at $0.16 on Friday. The stock has a market capitalization of $36.80 million, a PE ratio of -1.47 and a […]

Zacks: Analysts Anticipate Ampio Pharmaceuticals, Inc (NYSE:AMPE) to Announce -$0 02 Earnings Per Share

Brokerages expect Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Rating) to announce earnings per share (EPS) of ($0.02) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Ampio Pharmaceuticals’ earnings. Ampio Pharmaceuticals also posted earnings of ($0.02) per share in the same quarter last year. The firm is expected to […]

Brokerages Anticipate Ampio Pharmaceuticals, Inc (NYSE:AMPE) Will Post Earnings of -$0 02 Per Share

Equities research analysts expect that Ampio Pharmaceuticals, Inc. (NYSE:AMPE – Get Rating) will announce earnings of ($0.02) per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Ampio Pharmaceuticals’ earnings. Ampio Pharmaceuticals also posted earnings per share of ($0.02) during the same quarter last year. The business is […]

Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Rating) in a report released on Sunday. The firm set a “sell” rating on the stock. Shares of Ampio Pharmaceuticals stock opened at $0.28 on Friday. The business’s fifty day simple moving average is $0.44. Ampio Pharmaceuticals has a 1 year low of $0.21 […]

Alliance Global Partners Lowers Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Price Target to $3 00

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) had its price target reduced by equities research analysts at Alliance Global Partners from $4.50 to $3.00 in a report issued on Friday, The Fly reports. Separately, Zacks Investment Research lowered shares of Ampio Pharmaceuticals from a “hold” rating to a “strong sell” rating in a report on Friday, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.